Last reviewed · How we verify
NCT06916845
Data Collection for CV-3E AI Software Development
NA trial testing Colon Capsule in Colonic Polyps in 86 participants. Completed in 6 June 2025.
6 June 2025
Quick facts
| Lead sponsor | Capso Vision, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 86 |
| Start date | 16 March 2025 |
| Primary completion | 6 June 2025 |
| Estimated completion | 6 June 2025 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Colon Capsule
Conditions studied
- Colonic Polyps — all drugs for Colonic Polyps →
Sponsor
Capso Vision, Inc.
Who can join
Adults 45 to 75, any sex, with Colonic Polyps. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to collect capsule images for the development of CADe software for use with the CapsoCam® Colon (CV-3E) in healthy volunteers who have been referred for colonoscopy. There will be no analysis performed as part of this protocol. Participants will * adhere to bowel prep instructions and dietary requirements * ingest pro-kinetic medication and CapsoCam® Colon (CV-3E) * adhere to booster regimen and dietary requirements until capsule passes * retrieve capsule with retrieval kit per instructions and mail back to sponsor * participate in follow-up phone call
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06916845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colonic Polyps
Currently open trials in the same condition.
- NCT07467928 — The Long-term Effect of Artificial Intelligence-assisted Colonoscopy on Risk of Metachronous Advanced Colonic Lesion · NA · recruiting
- NCT06961149 — Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate · NA · recruiting
Other Capso Vision, Inc. trials
Trials by the same sponsor.
- NCT04607746 — Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference · NA · completed
- NCT04246632 — CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC) · NA · completed
- NCT03685903 — Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure. · Phase 1 · unknown
- NCT04573959 — Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06916845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Capso Vision, Inc.
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06916845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing